News und Analysen

Gene editing, a set of techniques used to alter sections of an organism's DNA, is helping scientists cure diseases previously considered untreatable. That's why biotechs that specialize in gene

Many investors have adopted a passive investing approach that incorporates heavy allocations to exchange-traded funds. By using ETFs, investors can easily build a portfolio that has a ton of diversi

There were times when investors may have worried about hanging onto AbbVie (NYSE: ABBV) stock.

A decade ago, more than 63% of the pharmaceutical giant's revenue was tied up in one drug -- Humira

Eli Lilly's (NYSE: LLY) big problem is its success in the GLP-1 drug space. Its Mounjaro (for diabetes) and Zepbound (for weight loss) drugs grew sales by 99% and 175%, respectively, in 2025.

That's

Blue chip dividend stocks are usually stable long-term investments, but they lost their luster in 2022 and 2023 as rising interest rates made CDs and T-bills more attractive. However, the Federal

You've heard a lot about how stocks can help make you rich. But what if you don't have the time to spend digging through hundreds or even thousands of different companies looking for the ones that

Broader equities have been relatively volatile over the past few months. In an environment like this, it's best to prioritize investing in well-established, profitable corporations. While small-cap

Cathie Wood seems to always be making market moves. The founder and CEO of Ark Invest publishes her transactions at the end of every trading day, and that gives us all a great way to track one of

If you ask me for a reason I'd buy Pfizer (NYSE: PFE) stock and never sell it, I certainly have one -- because I've already bought into Pfizer, and I have no plans to sell it. Here's a look at why I

Dividend stocks can make for great long-term investments. They can generate a steady stream of income for your portfolio, not only padding your overall returns but also providing you with a way to

For years, UnitedHealth Group (NYSE: UNH) stock has been a terrific growth investment. In fact, it looked unstoppable. Not only did it repeatedly grow its dividend, but the stock was amassing some

Matthew Strobeck, a Board Director at QuidelOrtho Corp. (NASDAQ:QDEL), reported the purchase of 10,000 common shares on Feb. 13, 2026, for a total transaction value of ~$240,000, as disclosed in a

On Feb. 24, 2026, Ardelyx (NASDAQ:ARDX) President and CEO Michael Raab reported the sale of 41,666 shares of Common Stock for approximately $261,000, according to a SEC Form 4 filing.

Transaction

The four largest hyperscalers (owners of large data centers) have said they have plans to spend more than $650 billion this year building out their artificial intelligence (AI) infrastructure. Let's

Investing in individual stocks can make you rich. But in stark contrast to many of the promotional materials you'll see just about everywhere on the internet, stock investing isn't always easy. For

Regencell Bioscience (NASDAQ: RGC), a China-based drugmaker, has been on fire over the past 12 months, with its share price skyrocketing by more than 21,000% as of this writing (that's not a typo)

Eli Lilly (NYSE: LLY) is growing very quickly right now thanks to Mounjaro and Zepbound, its two GLP-1 drugs, the latter of which is approved for weight loss. Mounjaro's sales rose 99% in 2025, and

It's easy to think that Amazon's (NASDAQ: AMZN) best days must be behind it. The company has grown from the garage of founder Jeff Bezos to become a multi-trillion-dollar enterprise in the span of

When it comes to medical devices, some of the most exciting ones, to me, are robotic surgical systems. Intuitive Surgical has been a leader in that arena, averaging annual gains of 19% over the past

In the 1990s, a group of research analysts worked at a prominent hedge fund, Tiger Management, led by the legendary investor Julian Robertson. After Tiger closed down, many of these analysts went on

Exelixis (NASDAQ: EXEL) is a relatively small biotech company with big dreams -- to become, as its executives said at a presentation in December, a "top five solid tumor oncology company."

The

In the long run, the value of a company relies on its ability to make money. However, there are different pathways to profitability for young businesses. Historically, many businesses concentrated

Broadly speaking, investing in semiconductor stocks has been a wise choice over the last year. As artificial intelligence (AI) hyperscalers double down on infrastructure budgets, the need to secure

Investors look to the recent moves of billionaires for one clear reason: They've demonstrated their knowledge of the stock market by choosing many winning investments over the years. But how do we